The Vision Fund’s vision remains a little bit blurry via @FT https://t.co/FTjCgAo4CE — The Propell Group (@ThePropellGroup) May 13, 2018
https://t.co/mheC6iwzgh — The Propell Group (@ThePropellGroup) May 12, 2018
The Economist | The payers’ revolt via @TheEconomist https://t.co/hyOSoM8byZ — The Propell Group (@ThePropellGroup) May 12, 2018
Donald Trump set to unveil measures to bring down drug prices via @FT https://t.co/VQMEhhlhPT — The Propell Group (@ThePropellGroup) May 11, 2018
This GV-Backed Company Thinks Its “Robotic Pill” Could Replace Painful Drug Injections https://t.co/GfbzEyKXSQ
0 0
This GV-Backed Company Thinks Its “Robotic Pill” Could Replace Painful Drug Injections https://t.co/GfbzEyKXSQ — The Propell Group (@ThePropellGroup) May 10, 2018
https://t.co/LbPAGyMLZo — The Propell Group (@ThePropellGroup) May 10, 2018
https://t.co/HeUXzOh6CQ — The Propell Group (@ThePropellGroup) May 10, 2018
https://t.co/lwaK6VIdXw — The Propell Group (@ThePropellGroup) May 10, 2018
AI activity is ‘strikingly similar to brain cells’ via @FT https://t.co/TVl85FUe88 — The Propell Group (@ThePropellGroup) May 10, 2018
Banks scramble to assemble Asian biotech IPO resources via @FT https://t.co/4PAHrqjMET — The Propell Group (@ThePropellGroup) May 9, 2018